A recent study reported significant association of late-onset Alzheimer's disease (LOAD) with multiple single nucleotide polymorphisms (SNPs) and haplotypes in SORL1, a neuronal sortilin-related receptor protein known to be involved in the trafficking and processing of amyloid precursor protein. Here we attempted to validate this finding in three large, well characterized case-control series. Approximately 2000 samples from the three series were individually genotyped for 12 SNPs, including the 10 reported significant SNPs and 2 that constitute the reported significant haplotypes. A total of 25 allelic and haplotypic association tests were performed. One SNP rs2070045 was marginally replicated in the three sample sets combined (nominal P = 0.035); however, this result does not remain significant when accounting for multiple comparisons. Further validation in other sample sets will be required to assess the true effects of SORL1 variants in LOAD.
Introduction
Late-onset Alzheimer's disease (LOAD) is a complex, neurodegenerative disease that primarily manifests itself in the deterioration and loss of cognitive abilities. Susceptibility to the disease is strongly affected by genetic factors (Gatz et al., 2006) , with apolipoprotein E4 (APOE4) likely to play a major role in the predisposition to the condition (Strittmatter et al., 1993) . There is no consensus on the identities of other genetic risk factors, although many others have been proposed that have either failed replication or not yet been tested in independent sample sets.
Recently, Rogaeva et al. (2007) reported a role of the neuronal sortilin-related receptor SORL1 in the genetics of LOAD, after testing single nucleotide polymorphisms (SNPs) in several members of the vacuolar protein sorting gene family for association with the disease. They tested multiple LOAD sample sets from different ethnic backgrounds and identified 10 SNPs (SNP numbers 4, (8) (9) (10) 12, 17, 19, (23) (24) (25) in the Rogaeva publication) and 4 haplotypes (8-9-10, 9-10-11, 22-23-24, and 23-24-25) in SORL1 that are significantly associated with LOAD in at least one individual sample set or a meta-analysis of several sample sets combined. SORL1 is known to be involved in intracellular transport and processing of the amyloid precursor protein (Andersen et al., 2005; Offe et al., 2006) , thus genetic variation in SORL1 may affect predisposition to LOAD. However, genetic association studies have often produced spurious findings, and thus require validation in multiple other sample sets (Ioannidis, 2005; Moonesinghe et al., 2007) . In this study, we specifically tested all the reported significant SORL1 markers and haplotypes in~2000 Caucasian samples from three well-characterized LOAD case-control series.
Materials and methods

Samples
Three LOAD case-control sample sets, collected with informed consent/assent from the participating individuals and approvals from the participating institutions, were used in the current study. The WU sample set (WU) was obtained from the Washington University Alzheimer's Disease Research Center, and the UK1 and UK2 sample sets were obtained from the Cardiff University. These sample sets consist of 377 cases and 376 controls (WU), 343 cases and 346 controls (UK1), and 278 cases and 311 controls (UK2), respectively. Cases had a minimum age at disease onset of 60 years and a diagnosis of probable or definite Alzheimer's disease (NINCDS-ADRDA), with mean age at onset of 76.2 ± 6.9 years (WU), 75.8 ± 6.9 years (UK1), and 76.3 ± 7.1 years (UK2). Controls were ascertained at the age of ≥ 65 years and screened for evidence of dementia (MMSE = 28, clinical dementia rating = 0, or full neurological exam); the mean age at examination is 77.4 ± 7.5 years (WU), 76.4 ± 6.1 years (UK1), and 76.5 ± 5.6 years (UK2). All individuals are of Caucasian origins, and females account for 63.9% of cases and 62.8% of controls in the WU sample set, 77.6% of cases and 75.1%
